Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125289393 | 12528939 | 3 | F | 20160625 | 20160819 | 20160705 | 20160823 | EXP | JP-SA-2016SA120493 | AVENTIS | 72.00 | YR | A | M | Y | 0.00000 | 20160823 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125289393 | 12528939 | 1 | PS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | DOSE:10 UNIT(S) | U | UNK | 21081 | QD | |||||||
| 125289393 | 12528939 | 2 | SS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | DOSE:6 UNIT(S) | U | UNK | 21081 | QD | |||||||
| 125289393 | 12528939 | 3 | SS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | DOSE:3 UNIT(S) | U | UNK | 21081 | QD | |||||||
| 125289393 | 12528939 | 4 | SS | LASIX | FUROSEMIDE | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125289393 | 12528939 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | U | UNKNOWN | 20839 | |||||||||
| 125289393 | 12528939 | 6 | SS | TRAZENTA | LINAGLIPTIN | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 125289393 | 12528939 | 7 | SS | VOGLIBOSE | VOGLIBOSE | 1 | Unknown | U | UNK | 0 | |||||||||
| 125289393 | 12528939 | 8 | SS | MICAMLO | AMLODIPINE BESYLATETELMISARTAN | 1 | Unknown | U | UNK | 0 | |||||||||
| 125289393 | 12528939 | 9 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | U | UNK | 0 | |||||||||
| 125289393 | 12528939 | 10 | SS | VESICARE | SOLIFENACIN SUCCINATE | 1 | Unknown | U | UNK | 0 | |||||||||
| 125289393 | 12528939 | 11 | SS | NICORANDIL | NICORANDIL | 1 | Unknown | U | UNK | 0 | |||||||||
| 125289393 | 12528939 | 12 | SS | ASPARA POTASSIUM | POTASSIUM ASPARTATE | 1 | Unknown | U | UNK | 0 | |||||||||
| 125289393 | 12528939 | 13 | SS | CARVEDILOL. | CARVEDILOL | 1 | Unknown | U | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125289393 | 12528939 | 5 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125289393 | 12528939 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125289393 | 12528939 | Ascites | |
| 125289393 | 12528939 | Blood glucose increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125289393 | 12528939 | 2 | 20160617 | 0 | ||
| 125289393 | 12528939 | 3 | 20160618 | 0 |